Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception
Authors:
- M.KAthleen ClarkMCM.KAthleen Clark
- MaryFran SowersMSMaryFran Sowers
- Barcey T LevyBLBarcey T Levy
- Patricia TenhundfeldPTPatricia Tenhundfeld
- 1 May 2001
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (5) , 871-877
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Forearm bone density in users of Depo-Provera as a contraceptive methodFertility and Sterility, 1999
- Bone density in long term users of depot medroxyprogesterone acetateBJOG: An International Journal of Obstetrics & Gynaecology, 1998
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- Depot Medroxyprogesterone Acetate and Breast CancerDrug Safety, 1996
- Differential effects on bone density of progestogen-only methods for contraception in premenopausal womenContraception, 1995
- Recovery of bone density in women who stop using medroxyprogesterone acetateBMJ, 1994
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991
- Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera®) as a contraceptive agentEuropean Journal of Endocrinology, 1982
- Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agentContraception, 1973
- Long‐Term Use of Depot Medroxy Progesterone Acetate as a ContraceptiveActa Obstetricia et Gynecologica Scandinavica, 1972